Merck KGaA expects MS pill to lift drugs margin
German pharmaceuticals and chemicals company Merck KGaA is banking on an experimental multiple sclerosis (MS) pill to lift operating margins at its embattled drugs unit, it said on Wednesday.
Read more on Reuters via Yahoo! News